Table 4.
The results of the main meta-analysis and leave-one-out sensitivity analysis of the prevalence of MME among glaucoma patients.
| Model | Model Description | ES (95% CI) | I2 |
|---|---|---|---|
| 1 | Excluding [Wolff et al.] [17] | 0.07 (0.04–0.11) | 91.20% |
| 2 | Excluding [Brazerol et al.] [30] | 0.10 (0.06–0.14) | 92.23% |
| 3 | Excluding [El Maftouhi et al.] [31] | 0.09 (0.05–0.12) | 91.94% |
| 4 | Excluding [Hasegawa et al.] [16] | 0.09 (0.05–0.12) | 92.00% |
| 5 | Excluding [Hasegawa et al.] [19] | 0.08 (0.04–0.11) | 91.62% |
| 6 | Excluding [Jiramongkolchai et al.] [8] | 0.09 (0.05–0.13) | 92.20% |
| 7 | Excluding [Mahmoudinezhad et al.] [21] | 0.08 (0.05–0.12) | 92.40% |
| 8 | Excluding [Murata et al.] [20] | 0.10 (0.06–0.14) | 89.58% |
| 9 | Excluding [Wen et al.] [14] | 0.10 (0.06–0.14) | 89.37% |
| 10 | Excluding [Govetto et al.] [6] | 0.06 (0.04–0.08) | 69.66% |
| Final Model | Inclusive of all studies | 0.08 (0.05–0.12) | 91.28% |
ES effect size (pooled prevalence), I2 measure of heterogeneity, MME microcystic macular edema, CI confidence interval.